The following advice is for the management of patients taking DMARDs for rheumatology related conditions. General guidance on management of rheumatology patients during COVID-19 is…
This document is intended to support local discussions on how to monitor commonly prescribed high risk medicines in primary care. Comments have been included as…
Disease-modifying anti-rheumatic drugs (DMARDs) have a varied pharmacology, mainly either modifying the immune response to the disease or modifying the disease process. The choice of…
These drugs are used for a variety of metabolic conditions, most of which are rare, and therefore give very limited opportunity to assess their impact…